T/GDNAS 055-2024 Recognizing and caring for adverse reactions to immun checkpoint inhibitors in cancer patients

Scope

Scope: This document stipulates the basic requirements for the identification and care of adverse reactions to immune checkpoint inhibitors in tumor patients, the identification and care pathways for adverse reactions to immune checkpoint inhibitors, the identification of risk factors for adverse reactions to immune checkpoint inhibitors, the grading judgment of adverse reactions to immune checkpoint inhibitors, the nursing care of adverse reactions to immune checkpoint inhibitors, and the follow-up of adverse reactions to immune checkpoint inhibitors. This document is applicable to registered nurses engaged in immunotherapy-related work in all levels and types of medical institutions. Main technical content: This document stipulates the basic requirements for the identification and care of adverse reactions to immune checkpoint inhibitors in tumor patients, the identification and care pathways for adverse reactions to immune checkpoint inhibitors, the identification of risk factors for adverse reactions to immune checkpoint inhibitors, the grading judgment of adverse reactions to immune checkpoint inhibitors, the nursing care of adverse reactions to immune checkpoint inhibitors, and the follow-up of adverse reactions to immune checkpoint inhibitors.

Development Information

Related Standards